Erste Asset Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-66,300
Closed -$2.59M – 596
2023
Q2
$2.59M Hold
66,300
– – 0.05% 256
2023
Q1
$1.58M Buy
66,300
+14,300
+28% +$313K 0.03% 303
2022
Q4
$1.09M Buy
52,000
+27,000
+108% +$576K 0.02% 347
2022
Q3
$432K Hold
25,000
– – 0.01% 438
2022
Q2
$242K Hold
25,000
– – 0.01% 498
2022
Q1
$408K Buy
+25,000
New +$369K 0.01% 456

Erste Asset Management's ISEE Position: Q3 2023 in Review

Erste Asset Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 66,300 shares — an estimated $2.59M sold.

Erste Asset Management first reported a position in ISEE in Q1 2022 and held it in 6 quarters. The position peaked at $2.59M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Erste Asset Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
  • Erste Asset Management sold 66,300 IVERIC bio shares in Q3 2023, an estimated $2.59M.
  • Erste Asset Management first reported a position in IVERIC bio in Q1 2022 and held it in 6 quarters.
  • Erste Asset Management's IVERIC bio position peaked at $2.59M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.